Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Ringe JD. Zoledronic acid in the treatment of Paget's disease and other benign bone disorders. Expert Rev Endocrinol Metab 2006;1:15-24. [PMID: 30743765 DOI: 10.1586/17446651.1.1.15] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]

For:	Ringe JD. Zoledronic acid in the treatment of Paget's disease and other benign bone disorders. Expert Rev Endocrinol Metab 2006;1:15-24. [PMID: 30743765 DOI: 10.1586/17446651.1.1.15] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]

Number

Cited by Other Article(s)

Khan A, Fortier M. Ostéoporose pendant la ménopause. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA 2016;38:S465-S483. [DOI: 10.1016/j.jogc.2016.09.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Bone Health. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA 2009. [DOI: 10.1016/s1701-2163(16)34078-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]

Ringe JD, Nitschmann S. [Zoledronic acid for preventing fractures. HORIZON trial (Health Outcomes and Reduced Incidence with Zoledronic acid ONce yearly)]. Internist (Berl) 2008;49:502-4. [PMID: 18305914 DOI: 10.1007/s00108-008-2067-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]